In this article, we discuss the 5 best performing actively managed ETFs in 2022. If you want to read about some more ETFs, go directly to 10 Best Performing Actively Managed ETFs in 2022.
5. AdvisorShares Ranger Equity Bear ETF (NYSE:HDGE)
Year-to-Date Return in 2022 as of December 29: 18.85%
The Sub-Advisor tries to accomplish the fund’s investment goal by short-selling a portfolio of liquid mid- and large-cap US exchange-traded equity instruments, ETFs, ETNs, and other exchange-traded products. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in short positions in equities securities. The Sub-Advisor employs a bottom-up, basic, research-driven security selection method.
As of December 29, the AdvisorShares Ranger Equity Bear ETF holds a volume of 122,400 along with net assets of $132.15 million. The net expense ratio of this ETF is 4.29% along with a yield of 0%. The net asset value is $28.78, and the current share price of this ETF is $28.74.
PG&E Corporation (NYSE:PCG) engages in the sale and delivery of electricity and natural gas to customers in northern and central California, the United States. It is one of the top 10 holdings in this ETF with 5.03% assets. Among the hedge funds being tracked by Insider Monkey, New York-based investment firm Third Point is a leading shareholder in PG&E Corporation (NYSE:PCG) with 63 million shares worth more than $792.5 million.
In its Q3 2022 investor letter, ClearBridge Investments, an asset management firm, highlighted a few stocks and PG&E Corporation (NYSE:PCG) was one of them. Here is what the fund said:
“PG&E Corporation (NYSE:PCG) is a regulated utility operating in central and northern California that serves 5.3 million electricity customers and 4.4 million gas customers in 47 of the state’s 58 counties. PG&E outperformed over the quarter after two pieces of California legislation passed that were seen as constructive and supportive of the company’s investment plans. There was a further positive announcement at the end of the quarter when S&P decided to add the company to the S&P 500 Index, opening the door for broader ownership.”
4. AdvisorShares Dorsey Wright Short ETF (NASDAQ:DWSH)
Year-to-Date Return in 2022 as of December 29: 18.85%
The AdvisorShares Dorsey Wright Short ETF is managed by Nasdaq Dorsey Wright, a firm renowned for relative strength investing. The Fund seeks capital appreciation through short-selling securities. Under normal circumstances, the Fund invests at least 80% of its assets in short sales of US-traded equity securities and exchange-traded funds to obtain short exposure to investment returns of the broad US large-capitalization equity market.
As of December 29, AdvisorShares Dorsey Wright Short ETF holds a volume of 75,700 along with net assets of $38.16 million. The net expense ratio of the fund is 2.77% along with a yield of 0.00%. The net asset value is $9.95, and the current share price of this ETF is $9.94.
FibroGen, Inc. (NASDAQ:FGEN) is one of the top 10 holdings of this ETF with 1.25% assets. It is a biopharmaceutical company that discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Among the hedge funds being tracked by Insider Monkey, Stamford-based investment firm Point72 Asset Management is a leading shareholder in FibroGen, Inc. (NASDAQ:FGEN) with 39.3 million shares worth more than $9 billion.
At the end of the third quarter of 2022, 19 hedge funds in the database of Insider Monkey held stakes worth $205 million in FibroGen, Inc. (NASDAQ:FGEN), compared to 15 in the previous quarter worth $132 million.
3. AGFiQ U.S. Market Neutral Anti-Beta Fund (NASDAQ:FTSM)
Year-to-Date Return in 2022 as of December 29: 21.76%
AGFiQ U.S. Market Neutral Anti-Beta Fund aims to provide a consistent negative beta exposure to the U.S. equity market. The fund will invest primarily in long positions in low-beta U.S. equities and short positions in high-beta U.S. equities on a dollar-neutral basis, within sectors.
As of December 29, AGFiQ U.S. Market Neutral Anti-Beta Fund holds a volume of 628,700 along with net assets of $383.14 million. The net expense ratio of the fund is 1.54% along with a yield of 0.00%. The net asset value is $21.20, and the current share price of this ETF is $21.26.
Moderna, Inc. (NASDAQ:MRNA) is one of the top 10 holdings in this ETF with 0.92% assets. It is a biotechnology company that discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. At the end of the third quarter of 2022, 44 hedge funds in the database of Insider Monkey held stakes worth $1.97 billion in Moderna, Inc. (NASDAQ:MRNA), compared to 45 in the previous quarter worth $2.6 billion.
In its Q3 2022 investor letter, Baron Funds, an asset management firm, highlighted a few stocks and Moderna, Inc. (NASDAQ:MRNA) was one of them. Here is what the fund said:
“Within biotechnology, the underperformance of Moderna, Inc. (NASDAQ:MRNA) and lower exposure to this better-performing sub-industry weighed the most on relative performance. Shares of Moderna, a leader in the emerging field of mRNA-based vaccines and therapeutics, declined due to increasing uncertainty around what a booster market could look like as COVID shifts away from pandemic status and becomes an increasingly commercial market rather than government funding.”
2. FolioBeyond Rising Rates ETF (NYSE:RISR)
Year-to-Date Return in 2022 as of December 29: 26.77%
This non-diversified fund’s primary investments are interest-only mortgage-backed securities (“MBS IOs”) and US Treasury bonds. The allocation ratio between MBS IOs and US Treasuries will vary based on relative value relationships such as historical yield levels compared to other financial assets, volatility and other risk measures (as determined by the sub-adviser), macro-environmental determinants such as inflation and economic growth, and other factors deemed relevant by the sub-adviser.
As of December 29, FolioBeyond Rising Rates ETF holds a volume of 24,500 along with net assets of $82.85 million. The fund’s net expense ratio is 0.99% along with a yield of 3.64%. The net asset value is $31.53, and the current share price of this ETF is $31.65.
1. AXS Short Innovation Daily ETF (NASDAQ:SARK)
Year-to-Date Return in 2022 as of December 29: 56.48%
The is an actively managed ETF in which the adviser aims to achieve the inverse (-1x) of the ARK Innovation ETF’s daily return by entering into a swap agreement on the ARK Innovation ETF. The ARK Innovation ETF is an actively managed ETF that invests primarily in domestic and overseas equity securities of firms relevant to the fund’s investment theme of disruptive innovation. It is not diverse.
As of December 29, AXS Short Innovation Daily ETF holds a volume of 1,764,600 along with net assets of $317.76 million. The net expense ratio of AXS Short Innovation Daily ETF is 0.75%. The net asset value is $54.67, and the current share price of this ETF is $56.74.
You can also take a peek at 11 Best Penny Stocks To Buy and 12 Best Tech Stocks for Long-Term Growth.
